Jan van de Winkel, Chief Executive Officer of Genmab, likes late-stage advancement medicines to elevate sales, concentrating on commercialized items that can increase profits development.
发布者:BY MARKETWIRE,转转请注明出处:https://robotalks.cn/genmabs-ceo-were-scanning-the-market-for-acquisition-opportunities-to-boost-sales/